Lv4
504 积分 2021-10-22 加入
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
1天前
待确认
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
6天前
已完结
Unlocking the Immune Response in ALK-Rearranged Lung Adenocarcinoma
9天前
已关闭
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease
9天前
已完结
EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
9天前
已关闭
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
20天前
已完结
Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers
26天前
已完结
Kras G12C– and G12D–driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models
1个月前
已完结
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
1个月前
已完结
Activation of T Cell–Intrinsic p53 by Acetylation Elicits Antitumor Immunity to Boost Cancer Immunotherapy
1个月前
已完结
皖公网安备34019202002308
